Citigroup Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $52

Citigroup analyst Samantha Semenkow maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $46 to $52.